✦ LIBER ✦

FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer

✍ Scribed by Bertolini, F; Malavasi, N; Scarabelli, L; Fiocchi, F; Bagni, B; Giovane, C Del; Colucci, G; Gerunda, G E; Depenni, R; Zironi, S

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy in patients with resectable

✍ Mohamed Hebbar 📂 Article 📅 2005 🏛 Current Science Inc. 🌐 English ⚖ 317 KB

Regional chemotherapy of non-resectable

✍ K. H. Link; M. Kornmann; A. Formentini; G. Leder; E. Sunelaitis; M. Schatz; J. P 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 61 KB

OPTIMIZING THE APPROACH TO PATIENTS WITH

✍ Elgene Lim; Benjamin N. J. Thomson; Stefan Heinze; Michael Chao; Dishan Gunaward 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

Optimizing the approach to patients with

✍ John Ludbrook 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 26 KB

Detection and Management of Extrahepatic

✍ Yolanda Y. L. Yang; James W. Fleshman; Steven M. Strasberg 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 343 KB

Hepatic lymph node involvement in resect

✍ Norihiro Kokudo; Tadao Sato; Makoto Seki; Hirotoshi Ohta; Kaoru Azekura; Masashi 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 622 KB